The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
US targets three Iranian oil vessels after attack on Navy ships
Israel launches strikes on southern Lebanon
Anak Krakatau eruption disrupts more than 200 flights in Indonesia
Putin says US-Russia contacts beneficial as talks begin with Witkoff and Kushner
Chinese national rescued from Nepal tunnel 10 days after flash flood
US envoys Witkoff, Kushner arrive in Moscow for talks on peace in Ukraine
One dead, 11 people missing after mudslide in China's Jiangxi province
Philippine VP Duterte posts bail after arrest order for alleged grave threats
